Clinical Trials Browser

Fanconi Anemia, Complementation Group D1 × olaparib × 90 days × Clear all

NCT03344965 2026-01-05

Olaparib In Metastatic Breast Cancer

Phase 2 Active not recruiting

BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms